ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

BN Brachyury and Radiation in Chordoma

ClinicalTrials.gov ID: NCT03595228

Public ClinicalTrials.gov record NCT03595228. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 11:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Trial of BN-Brachyury and Radiation Therapy in Patients With Advanced Chordoma

Study identification

NCT ID
NCT03595228
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bavarian Nordic
Industry
Enrollment
29 participants

Conditions and interventions

Conditions

Interventions

  • BN-Brachyury plus radiation Biological

Biological

Eligibility (public fields only)

Age range
12 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 30, 2018
Primary completion
Dec 9, 2021
Completion
Jan 24, 2022
Last update posted
Apr 13, 2023

2018 – 2022

United States locations

U.S. sites
5
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
Mayo Clinic, Arizona Phoenix Arizona 85054
Mayo Clinic, Florida Jacksonville Florida 32224
Massachusetts General Hospital, Cancer Center Boston Massachusetts 02114
Washington University School of Medicine St Louis Missouri 63110
MD Anderson Cancer Center Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03595228, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2023 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03595228 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →